Hide metadata

dc.date.accessioned2024-06-25T15:53:22Z
dc.date.available2024-06-25T15:53:22Z
dc.date.created2024-04-18T15:19:50Z
dc.date.issued2024
dc.identifier.citationBang Madsen, Kathrine Bliddal, Mette Skoglund, Charlotte Borg Larsson, Henrik Munk-Olsen, Trine Madsen, Malene Galle Per Hove, Thomsen Bergink, Veerle Srinivas, Chaitra Cohen, Jacqueline M. Brikell, Isabell Liu, Xiaoqin . Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period. CNS Drugs. 2024, 38(4), 303-314
dc.identifier.urihttp://hdl.handle.net/10852/111251
dc.description.abstractBackground An increasing number of women of reproductive age are treated with attention-deficit hyperactivity disorder (ADHD) medication; however, patterns of ADHD medication use for women in the perinatal period have not been well described. Objective This study aimed to describe ADHD medication use patterns from 1 year before pregnancy to 1 year after delivery, and to describe sociodemographic characteristics and clinical features by medication trajectories. Methods The population-based cohort study included pregnancies in Denmark between 1997 and 2020, from the Medical Birth Register, by women who filled at least one prescription for ADHD medication from 12 months before pregnancy until 12 months after delivery. We applied group-based trajectory modeling to classify women into subgroups based on the identification of heterogeneous ADHD medication treatment patterns, and described the characteristics associated with these groups. Results Overall, we included 4717 pregnancies leading to liveborn singletons by 4052 mothers with a mean (standard deviation) age of 27.5 (5.6) years. We identified four treatment trajectories across pregnancy and the postpartum period: continuers (23.3%), discontinuers (41.8%), interrupters who ceased filling prescriptions during pregnancy but resumed postpartum (17.2%), and postpartum initiators (17.7%). Continuers were older at the time of conception, gave birth in more recent years, were more likely to smoke during pregnancy, and used other psychotropic medications during pregnancy. A large proportion of continuers used methylphenidate (89.1%) compared with the other groups (75.9–84.1%) and had switched ADHD medication type during the whole period (16.4% vs. 7.4–14.8%). Conclusion We found that approximately 60% of women discontinued or interrupted their ADHD medication around pregnancy, and those who continued differed in sociodemographic and clinical factors that may reflect more severe ADHD.
dc.languageEN
dc.publisherAdis International
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleAttention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period
dc.title.alternativeENEngelskEnglishAttention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period
dc.typeJournal article
dc.creator.authorBang Madsen, Kathrine
dc.creator.authorBliddal, Mette
dc.creator.authorSkoglund, Charlotte Borg
dc.creator.authorLarsson, Henrik
dc.creator.authorMunk-Olsen, Trine
dc.creator.authorMadsen, Malene Galle
dc.creator.authorPer Hove, Thomsen
dc.creator.authorBergink, Veerle
dc.creator.authorSrinivas, Chaitra
dc.creator.authorCohen, Jacqueline M.
dc.creator.authorBrikell, Isabell
dc.creator.authorLiu, Xiaoqin
cristin.unitcode185,52,14,0
cristin.unitnameAvdeling for samfunnsmedisin og global helse
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2262828
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=CNS Drugs&rft.volume=38&rft.spage=303&rft.date=2024
dc.identifier.jtitleCNS Drugs
dc.identifier.volume38
dc.identifier.issue4
dc.identifier.startpage303
dc.identifier.endpage314
dc.identifier.doihttps://doi.org/10.1007/s40263-024-01076-1
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1172-7047
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International